Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Clin Immunol. 2021 Jun 16;229:108778. doi: 10.1016/j.clim.2021.108778

Figure 1: Study Population.

Figure 1:

Legend: 309 potential participants were identified from patient advocacy group databases; 169 completed the survey. Those who had died prior to receiving HCT or GT or who had never received HCT or GT were excluded from analysis. Of the 151 subjects analyzed, 107 had survived to at least 2 years after HCT or GT.